These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 9443474)

  • 41. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.
    Andreasen N; Vanmechelen E; Van de Voorde A; Davidsson P; Hesse C; Tarvonen S; Räihä I; Sourander L; Winblad B; Blennow K
    J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):298-305. PubMed ID: 9527138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism.
    Reiman EM; Chen K; Alexander GE; Caselli RJ; Bandy D; Osborne D; Saunders AM; Hardy J
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8299-302. PubMed ID: 15932949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Higher cathepsin B levels in plasma in Alzheimer's disease compared to healthy controls.
    Sundelöf J; Sundström J; Hansson O; Eriksdotter-Jönhagen M; Giedraitis V; Larsson A; Degerman-Gunnarsson M; Ingelsson M; Minthon L; Blennow K; Kilander L; Basun H; Lannfelt L
    J Alzheimers Dis; 2010; 22(4):1223-30. PubMed ID: 20930303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
    Hampel H; Teipel SJ; Fuchsberger T; Andreasen N; Wiltfang J; Otto M; Shen Y; Dodel R; Du Y; Farlow M; Möller HJ; Blennow K; Buerger K
    Mol Psychiatry; 2004 Jul; 9(7):705-10. PubMed ID: 14699432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry.
    Merched A; Serot JM; Visvikis S; Aguillon D; Faure G; Siest G
    FEBS Lett; 1998 Mar; 425(2):225-8. PubMed ID: 9559653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.
    Dayon L; Wojcik J; Núñez Galindo A; Corthésy J; Cominetti O; Oikonomidi A; Henry H; Migliavacca E; Bowman GL; Popp J
    J Alzheimers Dis; 2017; 60(4):1641-1652. PubMed ID: 29125490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
    Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM
    Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of APOE Genotype on Alzheimer's Disease CSF Biomarkers in a Spanish Population.
    Monge-Argilés JA; Gasparini-Berenguer R; Gutierrez-Agulló M; Muñoz-Ruiz C; Sánchez-Payá J; Leiva-Santana C
    Biomed Res Int; 2016; 2016():1390620. PubMed ID: 27092308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotype.
    Gabryelewicz T; Religa D; Styczynska M; Peplonska B; Pfeffer A; Wasiak B; Luczywek E; Golebiowski M; Androsiuk W; Czyzewski K; Przekop I; Barcikowska M
    Dement Geriatr Cogn Disord; 2002; 14(4):208-12. PubMed ID: 12411763
    [TBL] [Abstract][Full Text] [Related]  

  • 50. E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's disease.
    Corey-Bloom J; Tiraboschi P; Hansen LA; Alford M; Schoos B; Sabbagh MN; Masliah E; Thal LJ
    Neurology; 2000 Jan; 54(2):403-6. PubMed ID: 10668702
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.
    DeKosky ST; Ikonomovic MD; Wang X; Farlow M; Wisniewski S; Lopez OL; Becker JT; Saxton J; Klunk WE; Sweet R; Kaufer DI; Kamboh MI
    Ann Neurol; 2003 Jan; 53(1):81-90. PubMed ID: 12509851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The C677T variant in MTHFR modulates associations between blood-based and cerebrospinal fluid biomarkers of neurodegeneration.
    Roussotte FF; Narr KL; Small GW; Thompson PM;
    Neuroreport; 2016 Aug; 27(12):948-51. PubMed ID: 27380243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4.
    Kim KW; Suh YJ; Park WY; Jhoo JH; Lee DY; Youn JC; Lee KH; Seo JS; Woo JI
    Neurosci Lett; 2004 Aug; 366(2):182-6. PubMed ID: 15276243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.
    Gavett BE; John SE; Gurnani AS; Bussell CA; Saurman JL
    J Alzheimers Dis; 2016; 49(2):531-45. PubMed ID: 26444761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease.
    Combarros O; García-Román M; Fontalba A; Fernández-Luna JL; Llorca J; Infante J; Berciano J
    Dement Geriatr Cogn Disord; 2003; 15(3):151-4. PubMed ID: 12584430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease.
    Cruchaga C; Kauwe JS; Nowotny P; Bales K; Pickering EH; Mayo K; Bertelsen S; Hinrichs A; ; Fagan AM; Holtzman DM; Morris JC; Goate AM
    Hum Mol Genet; 2012 Oct; 21(20):4558-71. PubMed ID: 22821396
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease.
    Morris JK; Uy RAZ; Vidoni ED; Wilkins HM; Archer AE; Thyfault JP; Miles JM; Burns JM
    J Alzheimers Dis; 2017; 58(4):1129-1135. PubMed ID: 28550261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Head circumference and incident Alzheimer's disease: modification by apolipoprotein E.
    Gurwitz D; Chapman J; Weizman A
    Neurology; 2002 May; 58(9):1440. PubMed ID: 12011307
    [No Abstract]   [Full Text] [Related]  

  • 59. Influence of apolipoprotein E genotype on blood redox status of Alzheimer's disease patients.
    Fernandes MA; Proenca MT; Nogueira AJ; Grazina MM; Oliveira LM; Fernandes AI; Santiago B; Santana I; Oliveira CR
    Int J Mol Med; 1999 Aug; 4(2):179-86. PubMed ID: 10402486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease.
    Linnebank M; Popp J; Smulders Y; Smith D; Semmler A; Farkas M; Kulic L; Cvetanovska G; Blom H; Stoffel-Wagner B; Kölsch H; Weller M; Jessen F
    Neurodegener Dis; 2010; 7(6):373-8. PubMed ID: 20523031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.